CYP7A1 and metabolic syndrome: Dong et al. [40] recently revealed that miRNA-126-5P significantly interacted with peroxisome proliferator-activated receptor alpha (PPARα), ATP-binding cassette transporter (ABCA1), and cholesterol 7α-hydroxylase (CYP7A1) genes, ameliorating dyslipidemia and atherosclerosis.